News

Strategic collaboration for microbiome biomarker signatures and therapeutic discovery based on Genentech’s inflammatory bowel disease pipeline.

Measuring RNA fragments in a pregnant woman’s blood gives a reliable estimate of the baby’s due date and can predict if the baby will arrive prematurely, a Stanford-led team has shown.

Quadron Cannatech has announced that it has completed the sale of its first mobile extraction module to TLC Botanicals, located in Langley, British Columbia.

A new partnership has plans to improve cannabis plant yield, add diversity, promote immunity, and modify the physical and chemical traits of cannabinoid expressing plants.

Depression in type-1 diabetes patients is associated with higher levels of the inflammatory protein galectin-3. These findings suggest that galectin-3 levels may be a new target for treating depression associated with type-1 diabetes, which could lead to better patient care.

Researchers have shown that some tumors use not one but two levels of protection against the immune system. Knocking out one level boosted the protective effects of the second and vice versa. A two-pronged approach targeting both cell types simultaneously may offer a promising route for the development of new cancer immunotherapies.

Astrocytic activation in the hippocampus, a brain region that plays an important role in memory acquisition and consolidation.

A protein in the brain that binds to alcohol could be the key to curing alcoholism

The human glutamine transporter ASCT2 is upregulated in several forms of cancer. It is also the docking platform for a wide range of pathogenic retroviruses. A team of University of Groningen scientists have used cryo-electron microscopy to elucidate the structure of the protein, which may generate leads for drug development.

New technology improves on one that only a decade ago seemed magical.